DÄ internationalArchiveReferences
References

cme

The Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease

Dtsch Arztebl Int 2015; 112: 71-82. DOI: 10.3238/arztebl.2015.0071

Messmer, E M

1.The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007; 5: 75–92. CrossRef
2.Stern ME, Schaumburg CS, Pflugfelder SC: Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013; 32: 19–41. CrossRef MEDLINE PubMed Central
3.Stevenson W, Chauhan SK, Dana R: Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol 2012; 130: 90–100. CrossRef MEDLINE PubMed Central
4.Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD: Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 2012; 31: 472–8. CrossRef MEDLINE
5.Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ: Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2003; 31: 229–32. CrossRef
6.Schaumberg DA, Sullivan DA, Buring JE, Dana MR: Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318–26. CrossRef
7.Ruprecht KW, Giere W, Wulle KG: Statistical contribution on symptomatic dry eye. Ophthalmologica 1977; 174: 65–74. CrossRef MEDLINE
8.Bron AJ, Tomlinson A, Foulks GN, et al.: Rethinking dry eEye disease: A perspective on clinical implications. Ocul Surf 2014; 12: 1–31. CrossRef MEDLINE
9.Ridder WH 3rd, Zhang Y, Huang JF: Evaluation of reading speed and contrast sensitivity in dry eye disease. Optom Vis Sci 2013; 90: 37–44. CrossRef MEDLINE
10.Deschamps N, Ricaud X, Rabut G, Labbe A, Baudouin C, Denoyer A: The impact of dry eye disease on visual performance while driving. Am J Ophthalmol 2013; 156: 184–9. CrossRef MEDLINE
11.Li M, Gong L, Chapin WJ, Zhu M: Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci 2012; 53: 5722–7. CrossRef MEDLINE
12.Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W: Utility assessment among patients with dry eye disease. Ophthalmology 2003; 110: 1412–9. CrossRef
13.Labbe A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L: Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol 2013; 97: 1399–403. CrossRef MEDLINE
14.Yu J, Asche CV, Fairchild CJ: The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 2011; 30: 379–87. CrossRef MEDLINE
15.Foulks GN, Bron AJ: Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003; 1: 107–26. CrossRef
16.Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 163–78. CrossRef
17.Sullivan BD, Crews LA, Messmer EM, et al.: Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 2014; 92: 161–6. CrossRef MEDLINE
18.Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 108–52. CrossRef
19.Johnston PR, Rodriguez J, Lane KJ, Ousler G, Abelson MB: The interblink interval in normal and dry eye subjects. Clin Ophthalmol 2013; 7: 253–9. CrossRef MEDLINE PubMed Central
20.Arita R, Itoh K, Inoue K, Amano S: Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008; 115: 911–5. CrossRef MEDLINE
21.Nemeth J, Fodor E, Lang Z, et al.: Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study. Br J Ophthalmol 2012; 96: 1380–5. CrossRef MEDLINE
22.Höh H, Schirra F, Kienecker C, Ruprecht KW: Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye. Ophthalmologe 1995; 92: 802–8. MEDLINE
23.Jacobi C, Cursiefen C: Ophthalmological complications in Sjogren's syndrome. Z Rheumatol 2010; 69: 32–40. CrossRef MEDLINE
24.Vitali C, Bombardieri S, Jonsson R, et al.: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–8. CrossRef MEDLINE PubMed Central
25.Liew MS, Zhang M, Kim E, Akpek EK: Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 2012; 96: 1498–503. CrossRef MEDLINE
26.Messmer EM: Preservatives in ophthalmology. Ophthalmologe 2012; 109: 1064–70. CrossRef MEDLINE
27.Lee SY, Tong L: Lipid-containing lubricants for dry eye: a systematic review. Optom Vis Sci 2012; 89: 1654–61. CrossRef MEDLINE
28.Geerling G, Unterlauft JD, Kasper K, Schrader S, Opitz A, Hartwig D: Autologous serum and alternative blood products for the treatment of ocular surface disorders. Ophthalmologe 2008; 105: 623–31. CrossRef MEDLINE
29.Celebi AR, Ulusoy C, Mirza GE: The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol 2014; 252: 619–26. CrossRef MEDLINE
30.Marsh P, Pflugfelder SC: Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999; 106: 811–6. CrossRef
31.Pflugfelder SC, Maskin SL, Anderson B, et al.: A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138: 444–57. CrossRef MEDLINE
32.Sall K, Stevenson OD, Mundorf TK, Reis BL: Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107: 631–9. CrossRef
33.Yoo SE, Lee DC, Chang MH: The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 2005; 19: 258–63. CrossRef
34.Sadrai Z, Hajrasouliha AR, Chauhan S, Saban DR, Dastjerdi MH, Dana R: Effect of topical azithromycin on corneal innate immune responses. Invest Ophthalmol Vis Sci 2011; 52: 2525–31. CrossRef MEDLINE PubMed Central
35.Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW: Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 2010; 29: 781–8. MEDLINE PubMed Central
36.Barabino S, Rolando M, Camicione P, et al.: Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003; 22: 97–101. CrossRef MEDLINE
37.Geerling G, Tauber J, Baudouin C, et al.: The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52: 2050–64. CrossRef MEDLINE PubMed Central
38.Tai MC, Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR: The clinical efficacy of silicone punctal plug therapy. Cornea 2002; 21: 135–9. CrossRef
39.Horwath-Winter J, Thaci A, Gruber A, Boldin I: Long-term retention rates and complications of silicone punctal plugs in dry eye. Am J Ophthalmol 2007; 144: 441–4. CrossRef MEDLINE
40.Ervin AM, Wojciechowski R, Schein O: Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev 2010: CD006775. MEDLINE PubMed Central
e1. Goyal S, Chauhan SK, El Annan J, et al.: Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol 2010; 128: 819–24. MEDLINE PubMed Central
e2.Heiligenhaus A, Koch JM, Kruse FE, Schwarz C, Waubke TN: Diagnosis and and differentiation of dry eye disorders]. Diagnostik und Differenzierung von Benetzungsstörungen. Der Ophthalmologe 1995; 92: 6–11. MEDLINE
e3.Tong L, Chaurasia SS, Mehta JS, Beuerman RW: Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore. Invest Ophthalmol Vis Sci 2010; 51: 3449–54. CrossRef MEDLINE
e4.Lin PY, Tsai SY, Cheng CY, et al.: Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003; 110: 1096–101. CrossRef
e5.McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR: The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105: 1114–9. MEDLINE
e6.Moss SE, Klein R, Klein BE: Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118: 1264–8. CrossRef
e7.Schein OD, Hochberg MC, Munoz B, et al.: Dry eye and dry mouth in the elderly: a population-based assessment. Archiv Intern Med 1999; 159: 1359–63. CrossRef
e8.Kim JH, Kim JH, Nam WH, et al.: Oral alcohol administration disturbs tear film and ocular surface. Ophthalmology 2012; 119: 965–71. CrossRef MEDLINE
e9.Thomas J, Jacob GP, Abraham L, Noushad B: The effect of smoking on the ocular surface and the precorneal tear film. Australas Med J 2012; 5: 221–6. CrossRef MEDLINE PubMed Central
e10.Liu Z, Pflugfelder SC: Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106: 939–43. CrossRef
e11.Miljanovic B, Dana R, Sullivan DA, Schaumberg DA: Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143: 409–15. CrossRef MEDLINE PubMed Central
e12.Sullivan RM, Cermak JM, Papas AS, Dana MR, Sullivan DA: Economic and quality of life impact of dry eye symptoms in women with Sjogren's syndrome. Adv Exp Med Biol 2002; 506: 1183–8. CrossRef
e13.Paulsen AJ, Cruickshanks KJ, Fischer ME, et al.: Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 2014; 157: 799–806. CrossRef MEDLINE
e14.Golubovic S, Parunovic A: Corneal perforation in dry eye patients. Fortschr Ophthalmol 1987; 84: 33–7. MEDLINE
e15. Inagaki E, Ogawa Y, Matsumoto Y, et al.: Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis 2011; 17: 598–606. MEDLINE PubMed Central
e16.Krachmer JH, Laibson PR: Corneal thinning and perforation in Sjogren's syndrome. Am J Ophthalmol 1974; 78: 917–20. CrossRef
e17.Messmer EM, Hoops JP, Kampik A: Bilateral recurrent calcareous degeneration of the cornea. Cornea 2005; 24: 498–502. CrossRef
e18.Petroutsos G, Paschides CA, Kitsos G, Drosos AA, Psilas K: Sterile corneal ulcers in dry eye. II. Treatment, complications and course. J Fr Ophtalmol 1992; 15: 106–11. MEDLINE
e19.Pfister RR, Murphy GE: Corneal ulceration and perforation associated with Sjogren's syndrome. Archiv Ophthalmol 1980; 98: 89–94. CrossRef
e20.Stevenson W, Shikari H, Saboo US, Amparo F, Dana R: Bilateral corneal ulceration in ocular graft-versus-host disease. Clin Ophthalmol 2013; 7: 2153–8. MEDLINE PubMed Central
e21.Turgut B, Aydemir O, Kaya M, et al.: Spontaneous corneal perforation in a patient with lamellar ichthyosis and dry eye. Clin Ophthalmol 2009; 3: 611–3. CrossRef MEDLINE PubMed Central
e22.Henrich CF, Ramulu PY, Akpek EK: Association of dry eye and inflammatory systemic diseases in a tertiary care-based sample. Cornea 2014; 33: 819–25. CrossRef MEDLINE
e23.Abetz L, Rajagopalan K, Mertzanis P, et al.: Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes 2011; 9: 111. CrossRef MEDLINE PubMed Central
e24.Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL: Reliability and validity of the Ocular Surface Disease Index. Archiv Ophthalmol 2000; 118: 615–21. CrossRef
e25.Bentivoglio AR, Bressman SB, Cassetta E, et al.: Analysis of blink rate patterns in normal subjects. Mov Disord 1997; 12: 1028–34. CrossRef MEDLINE
e26.Freudenthaler N, Neuf H, Kadner G, Schlote T: Characteristics of spontaneous eyeblink activity during video display terminal use in healthy volunteers. Graefes Arch Clin Exp Ophthalmol 2003; 241: 914–20. CrossRef MEDLINE
e27.Bron AJ, Yokoi N, Gaffney EA, Tiffany JM: A solute gradient in the tear meniscus. I. A hypothesis to explain Marx's line. Ocul Surf 201; 9: 70–91.
e28.Werkmeister RM, Alex A, Kaya S, et al.: Measurement of tear film thickness using ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci 2013; 54: 5578–83. CrossRef MEDLINE
e29. Mainstone JC, Bruce AS, Golding TR: Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res 1996; 15: 653–61. CrossRef
e30.Lemp MA, Bron AJ, Baudouin C, et al.: Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011; 151: 792–8. CrossRef MEDLINE
e31.Messmer EM, Bulgen M, Kampik A: Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol 2010; 45: 129–38. CrossRef MEDLINE
e32.Sambursky R, Davitt WF, 3rd, Latkany R, et al.: Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013; 131: 24–8. CrossRef MEDLINE
e33.Barabino S, Rolando M, Nardi M, et al.: The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. Eur J Ophthalmol 2014; 24: 173–8. CrossRef MEDLINE
e34. Cohen S, Martin A, Sall K: Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophthalmol 2014; 8: 157–64. MEDLINE PubMed Central
e35.Diaz-Valle D, Arriola-Villalobos P, Garcia-Vidal SE, et al.: Effect of lubricating eyedrops on ocular light scattering as a measure of vision quality in patients with dry eye. J Cataract Refract Surg 2012; 38: 1192–7. CrossRef MEDLINE
e36.Doughty MJ: Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysis. Ocul Surf 2014; 12: 100–11. CrossRef MEDLINE
e37.Lee JH, Ahn HS, Kim EK, Kim TI: Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 2011; 30: 175–9. CrossRef MEDLINE
e38.Zhang Y, Potvin R, Gong L: A study of the short-term effect of artificial tears on contrast sensitivity in patients with Sjogren's syndrome. Invest Ophthalmol Vis Sci 2013; 54: 7977–82. CrossRef MEDLINE
e39.Craig JP, Purslow C, Murphy PJ, Wolffsohn JS: Effect of a liposomal spray on the pre-ocular tear film. Cont Lens Anterior Eye 2010; 33: 83–7. CrossRef MEDLINE
e40.Goto E, Shimazaki J, Monden Y, et al.: Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 2002; 109: 2030–5. CrossRef MEDLINE
e41.Khanal S, Tomlinson A, Pearce EI, Simmons PA: Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007; 26: 175–81. CrossRef MEDLINE
e42.Matsuda S, Koyasu S: Mechanisms of action of cyclosporine. Immunopharmacology 2000; 47: 119–25. CrossRef
e43.Yoshida A, Fujihara T, Nakata K: Cyclosporin A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice. Exp Eye Res 1999; 68: 541–6. CrossRef MEDLINE
e44.Baiza-Duran L, Medrano-Palafox J, Hernandez-Quintela E, Lozano-Alcazar J, Alaniz-de la OJ: A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome. Br J Ophthalmol 2010; 94: 1312–5. CrossRef MEDLINE
e45.Demiryay E, Yaylali V, Cetin EN, Yildirim C: Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome. Eye Contact Lens 2011; 37: 312–5. CrossRef MEDLINE
e46.Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK: Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000; 118: 1489–96. CrossRef
e47.Turner K, Pflugfelder SC, Ji Z, et al.: Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea 2000; 19: 492–6. CrossRef MEDLINE
e48.Moscovici BK, Holzchuh R, Chiacchio BB, et al.: Clinical treatment of dry eye using 0.03% tacrolimus eye drops. Cornea 2012; 31: 945–9. CrossRef MEDLINE
e49.Sanz-Marco E, Udaondo P, Garcia-Delpech S, Vazquez A, Diaz-Llopis M: Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops. J Ocul Pharmacol Ther 2013; 29: 776–83. CrossRef MEDLINE PubMed Central
e50.Auw-Hadrich C, Reinhard T: [Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors]. Behandlung der chronischen Blepharokeratokonjunktivitis mit lokalen Kalzineurininhibitoren. Ophthalmologe 2009; 106: 635–8. CrossRef MEDLINE
e51.Kuzin II, Snyder JE, Ugine GD, et al.: Tetracyclines inhibit activated B cell function. Int Immunol 2001; 13: 921–31. CrossRef MEDLINE
e52.Solomon A, Rosenblatt M, Li DQ, et al.: Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 2000; 41: 2544–57. MEDLINE
e53.Shine WE, McCulley JP, Pandya AG: Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res 2003; 76: 417–20. CrossRef
e54.Haque RM, Torkildsen GL, Brubaker K, et al.: Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea 2010; 29: 871–7. CrossRef MEDLINE
e55.McCulley JP, Shine WE: Meibomian secretions in chronic blepharitis. Adv Exp Med Biol 1998; 438: 319–26. CrossRef
e56.Guillon M, Maissa C, Wong S: Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction. Eye Contact Lens 2012; 38: 319–25. CrossRef MEDLINE
e57.Matsumoto Y, Dogru M, Goto E, et al.: Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea 2006; 25: 644–50. CrossRef MEDLINE
e58.Olson MC, Korb DR, Greiner JV: Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003; 29: 96–9. CrossRef MEDLINE
e59.Purslow C: Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction. Contact Lens Anterior Eye 2013; 36: 226–31. CrossRef MEDLINE
e60.Finis D, Hayajneh J, Konig C, et al.: Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf 2014; 12: 146–54. CrossRef MEDLINE
e61.Cohen EJ: Punctal occlusion. Arch Ophthalmol 1999; 117: 389–90. CrossRef
e62.Dursun D, Ertan A, Bilezikci B, Akova YA, Pelit A: Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion. Curr Eye Res 2003; 26: 263–9. CrossRef
e63.Roberts CW, Carniglia PE, Brazzo BG: Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea 2007; 26: 805–9. CrossRef MEDLINE
e64.Dimit R, Gire A, Pflugfelder SC, Bergmanson JP: Patient ocular conditions and clinical outcomes using a PROSE scleral device. Cont Lens Anterior Eye 2013; 36: 159–63. CrossRef MEDLINE
e65.Geerling G, Collin JR, Dart JK: Ophthalmic experience with submandibular gland transplantation for severe dry eyes. Laryngoscope 2009; 119: 1445–6. CrossRef MEDLINE